Guardant Health (GH) Competitors $54.86 -1.94 (-3.41%) As of 11:09 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock GH vs. VCYT, NTRA, HIMS, RDNT, OPCH, SHC, BTSG, WGS, CON, and SGRYShould you be buying Guardant Health stock or one of its competitors? The main competitors of Guardant Health include Veracyte (VCYT), Natera (NTRA), Hims & Hers Health (HIMS), RadNet (RDNT), Option Care Health (OPCH), Sotera Health (SHC), BrightSpring Health Services (BTSG), GeneDx (WGS), Concentra Group Holdings Parent (CON), and Surgery Partners (SGRY). These companies are all part of the "healthcare" industry. Guardant Health vs. Its Competitors Veracyte Natera Hims & Hers Health RadNet Option Care Health Sotera Health BrightSpring Health Services GeneDx Concentra Group Holdings Parent Surgery Partners Guardant Health (NASDAQ:GH) and Veracyte (NASDAQ:VCYT) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk. Do analysts prefer GH or VCYT? Guardant Health presently has a consensus price target of $58.24, indicating a potential upside of 6.14%. Veracyte has a consensus price target of $40.90, indicating a potential upside of 30.69%. Given Veracyte's higher possible upside, analysts clearly believe Veracyte is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Guardant Health 0 Sell rating(s) 0 Hold rating(s) 17 Buy rating(s) 1 Strong Buy rating(s) 3.06Veracyte 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70 Do insiders & institutionals believe in GH or VCYT? 92.6% of Guardant Health shares are owned by institutional investors. 6.1% of Guardant Health shares are owned by company insiders. Comparatively, 1.4% of Veracyte shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is GH or VCYT more profitable? Veracyte has a net margin of 5.50% compared to Guardant Health's net margin of -49.93%. Veracyte's return on equity of 6.07% beat Guardant Health's return on equity.Company Net Margins Return on Equity Return on Assets Guardant Health-49.93% N/A -28.95% Veracyte 5.50%6.07%5.53% Which has more volatility & risk, GH or VCYT? Guardant Health has a beta of 1.46, suggesting that its share price is 46% more volatile than the S&P 500. Comparatively, Veracyte has a beta of 2.07, suggesting that its share price is 107% more volatile than the S&P 500. Which has stronger earnings & valuation, GH or VCYT? Veracyte has lower revenue, but higher earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGuardant Health$739.02M9.26-$436.37M-$3.35-16.38Veracyte$445.76M5.52$24.14M$0.3394.83 Does the media favor GH or VCYT? In the previous week, Guardant Health had 11 more articles in the media than Veracyte. MarketBeat recorded 22 mentions for Guardant Health and 11 mentions for Veracyte. Guardant Health's average media sentiment score of 1.13 beat Veracyte's score of 1.04 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 15 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Veracyte 6 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryGuardant Health beats Veracyte on 9 of the 17 factors compared between the two stocks. Get Guardant Health News Delivered to You Automatically Sign up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GH vs. The Competition Export to ExcelMetricGuardant HealthMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.85B$3.18B$5.80B$10.16BDividend YieldN/A2.32%5.69%4.61%P/E Ratio-16.3921.4874.7325.99Price / Sales9.26301.34470.3491.76Price / CashN/A45.3337.0859.91Price / Book-48.559.6312.256.31Net Income-$436.37M-$53.32M$3.28B$270.66M7 Day Performance-8.76%0.95%1.39%3.52%1 Month Performance-0.43%9.68%7.70%6.79%1 Year Performance114.48%13.38%64.01%28.29% Guardant Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GHGuardant Health3.9853 of 5 stars$54.87-3.4%$58.24+6.1%+128.3%$6.85B$739.02M-16.392,021News CoveragePositive NewsInsider TradeVCYTVeracyte3.8778 of 5 stars$30.34+1.3%$40.90+34.8%+5.1%$2.39B$445.76M91.94790Positive NewsNTRANatera3.5024 of 5 stars$168.25+0.2%$193.19+14.8%+40.4%$23.09B$1.70B-88.094,434Positive NewsHIMSHims & Hers Health2.6865 of 5 stars$42.36-4.0%$38.92-8.1%+239.1%$9.57B$2.01B52.951,637Analyst ForecastRDNTRadNet3.4821 of 5 stars$71.760.0%$71.60-0.2%+18.3%$5.52B$1.83B-358.7811,021Positive NewsOPCHOption Care Health4.8436 of 5 stars$28.68-0.2%$35.75+24.7%-9.4%$4.65B$5.37B22.948,088Positive NewsSHCSotera Health2.1872 of 5 stars$16.37+1.0%$16.00-2.3%-0.4%$4.65B$1.12B204.653,000Insider TradeBTSGBrightSpring Health Services2.3358 of 5 stars$23.69-0.2%$25.67+8.3%+107.0%$4.20B$11.27B76.4235,000News CoverageAnalyst ForecastWGSGeneDx2.6044 of 5 stars$129.49+0.4%$101.63-21.5%+257.0%$3.72B$305.45M2,589.801,200Positive NewsAnalyst ForecastCONConcentra Group Holdings Parent3.0742 of 5 stars$23.78+0.2%$27.50+15.7%-3.7%$3.05B$1.90B19.9811,250Positive NewsSGRYSurgery Partners3.1969 of 5 stars$22.69-0.1%$33.00+45.4%-27.4%$2.91B$3.11B-15.8712,200Positive News Related Companies and Tools Related Companies Veracyte Alternatives Natera Alternatives Hims & Hers Health Alternatives RadNet Alternatives Option Care Health Alternatives Sotera Health Alternatives BrightSpring Health Services Alternatives GeneDx Alternatives Concentra Group Holdings Parent Alternatives Surgery Partners Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GH) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardant Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardant Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GH Stock Alerts